Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advanced Imaging for Pulmonary Fibrosis
NCT06532071Phase 2Recruiting
- Start
- Jan 2025
- Primary completion
- Dec 2028
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Gallium Ga 68 NODAGA-CBP8 in pulmonary fibrosis (PF). Started Jan 2025; status: recruiting.
02
Drugs
Gallium Ga 68 NODAGA-CBP8
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT06532071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06532071.